SHE - Short Term Hormone Effect Scale
Headline Headline Border
head_grafic developed_by the_ZEG_Berlin
sitemap:// home >> background

Background and objectives

Conceptual framework and intended application

Identification of concept and domains to be measured
It was the concept to develop an instrument to measure health-related quality of life, specifically related to changes due to use of sex-steroid hormones in women. The concept for the development followed recommendations of the FDA for Patient-Reported Outcomes (PRO).
It was anticipated that several domains could be found learning from known pharmacological effects of sex-steroid hormones and reported short-term outcomes of treatment with such hormones: Effects of psychological nature, on sexual symptoms, (pre-) menstrual problems (hormones even used as treatment of “diseases”), and pharmacological hormone-related effects on certain organs such as breast, hair and skin.

Intended application
A self-administrable scale was planned that is easy to apply, has a high acceptance in women, is easy to analyse, and can be applied in clinical trial as well in observational studies to describe a group, to compare results among groups (different locations or over time), and can be utilized as outcome measure.

Intended population
The scale should be applicable to women irrespective of age, but with some preference for younger age. Ethnicity, social class, and health status or other factors should not play a role.

Background Border
Development Border
Structure Border
Languages Border
Evaluation Border
References Border
Contact Border
Impressum Border
empty_placeholder Border
 printversion  |  sitemap  |  impressum 
foot_grafic foot_grafic link_to_ZEG_Home Page